Barry Koplowitz

In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans

Mary T. Obermeier, Ming Yao, Ashish Khanna et al. · Drug Metabolism and Disposition · 2009 · 176 citations

Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections

Aberra Fura, Ashish K. Khanna, Viral Vyas et al. · Drug Metabolism and Disposition · 2009 · 98 citations

Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity

Claudio Mapelli, Sesha Natarajan, Jean‐Philippe Meyer et al. · Journal of Medicinal Chemistry · 2009 · 70 citations · Full text

Metabolic Syndrome, Diabetes Management, Peptides 21 +15

Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers

R. Edward Hogan, Barry E. Gidal, Barry Koplowitz et al. · Epilepsia · 2020 · 64 citations · Full text

Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of <i>N</i>-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-<i>N</i>,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ET_A Selective Antagonist

Natesan Murugesan, Zhengxiang Gu, Steven H. Spergel et al. · Journal of Medicinal Chemistry · 2002 · 62 citations · Full text

Receptor Antagonist N-, Molecular Pharmacology, Medicinal Chemistry +15